The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Aerobic exercise significantly lowers Alzheimer’s disease markers and improves brain health, offering a promising preventive ...

Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...